Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2

Author:

Chemaitelly Hiam1,Ayoub Houssein H.2ORCID,Tang PatrickORCID,Hasan Mohammad R.,Coyle Peter3,Yassine Hadi M.,Al-Khatib Hebah A.,Smatti Maria K.,Al-Kanaani Zaina,Al-Kuwari Einas,Jeremijenko AndrewORCID,Kaleeckal Anvar H.,Latif Ali N.ORCID,Shaik Riyazuddin M.,Abdul-Rahim Hanan F.,Nasrallah Gheyath K.,Al-Kuwari Mohamed G.4,Butt Adeel A.3ORCID,Al-Romaihi Hamad E.,Al-Thani Mohamed H.,Al-Khal Abdullatif3,Bertollini Roberto5,Abu-Raddad Laith J.1ORCID

Affiliation:

1. Weill Cornell Medicine–Qatar, Doha, Qatar

2. Qatar University, Doha, Qatar

3. Hamad Medical Corporation, Doha, Qatar

4. Primary Health Care Corporation, Doha, Qatar

5. Ministry of Public Health, Doha, Qatar

Funder

Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine–Qatar

Qatar Ministry of Public Health; Hamad Medical Corporation; and Sidra Medicine

Qatar Genome Program and Qatar University Biomedical Research Center

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3